Table of Content

1 Short Sleep Syndrome Treatment Market Overview
1.1 Product Overview and Scope of Short Sleep Syndrome Treatment
1.2 Short Sleep Syndrome Treatment Segment by Type
1.2.1 Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2024-2034)
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonist
1.2.6 Melatonin Antagonist
1.2.7 Other
1.3 Short Sleep Syndrome Treatment Segment by Application
1.3.1 Global Short Sleep Syndrome Treatment Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Short Sleep Syndrome Treatment Market Size Estimates and Forecasts
1.4.1 Global Short Sleep Syndrome Treatment Revenue 2024-2034
1.4.2 Global Short Sleep Syndrome Treatment Sales 2024-2034
1.4.3 Global Short Sleep Syndrome Treatment Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Short Sleep Syndrome Treatment Market Competition by Manufacturers
2.1 Global Short Sleep Syndrome Treatment Sales Market Share by Manufacturers (2024-2024)
2.2 Global Short Sleep Syndrome Treatment Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Short Sleep Syndrome Treatment Average Price by Manufacturers (2024-2024)
2.4 Global Short Sleep Syndrome Treatment Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Short Sleep Syndrome Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short Sleep Syndrome Treatment, Product Type & Application
2.7 Short Sleep Syndrome Treatment Market Competitive Situation and Trends
2.7.1 Short Sleep Syndrome Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Short Sleep Syndrome Treatment Players Market Share by Revenue
2.7.3 Global Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Short Sleep Syndrome Treatment Retrospective Market Scenario by Region
3.1 Global Short Sleep Syndrome Treatment Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Short Sleep Syndrome Treatment Global Short Sleep Syndrome Treatment Sales by Region: 2024-2034
3.2.1 Global Short Sleep Syndrome Treatment Sales by Region: 2024-2024
3.2.2 Global Short Sleep Syndrome Treatment Sales by Region: 2024-2034
3.3 Global Short Sleep Syndrome Treatment Global Short Sleep Syndrome Treatment Revenue by Region: 2024-2034
3.3.1 Global Short Sleep Syndrome Treatment Revenue by Region: 2024-2024
3.3.2 Global Short Sleep Syndrome Treatment Revenue by Region: 2024-2034
3.4 North America Short Sleep Syndrome Treatment Market Facts & Figures by Country
3.4.1 North America Short Sleep Syndrome Treatment Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Short Sleep Syndrome Treatment Sales by Country (2024-2034)
3.4.3 North America Short Sleep Syndrome Treatment Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Short Sleep Syndrome Treatment Market Facts & Figures by Country
3.5.1 Europe Short Sleep Syndrome Treatment Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Short Sleep Syndrome Treatment Sales by Country (2024-2034)
3.5.3 Europe Short Sleep Syndrome Treatment Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short Sleep Syndrome Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Short Sleep Syndrome Treatment Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Short Sleep Syndrome Treatment Sales by Country (2024-2034)
3.6.3 Asia Pacific Short Sleep Syndrome Treatment Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Short Sleep Syndrome Treatment Market Facts & Figures by Country
3.7.1 Latin America Short Sleep Syndrome Treatment Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Short Sleep Syndrome Treatment Sales by Country (2024-2034)
3.7.3 Latin America Short Sleep Syndrome Treatment Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Short Sleep Syndrome Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Short Sleep Syndrome Treatment Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Short Sleep Syndrome Treatment Sales by Country (2024-2034)
3.8.3 Middle East and Africa Short Sleep Syndrome Treatment Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short Sleep Syndrome Treatment Sales by Type (2024-2034)
4.1.1 Global Short Sleep Syndrome Treatment Sales by Type (2024-2024)
4.1.2 Global Short Sleep Syndrome Treatment Sales by Type (2024-2034)
4.1.3 Global Short Sleep Syndrome Treatment Sales Market Share by Type (2024-2034)
4.2 Global Short Sleep Syndrome Treatment Revenue by Type (2024-2034)
4.2.1 Global Short Sleep Syndrome Treatment Revenue by Type (2024-2024)
4.2.2 Global Short Sleep Syndrome Treatment Revenue by Type (2024-2034)
4.2.3 Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2024-2034)
4.3 Global Short Sleep Syndrome Treatment Price by Type (2024-2034)
5 Segment by Application
5.1 Global Short Sleep Syndrome Treatment Sales by Application (2024-2034)
5.1.1 Global Short Sleep Syndrome Treatment Sales by Application (2024-2024)
5.1.2 Global Short Sleep Syndrome Treatment Sales by Application (2024-2034)
5.1.3 Global Short Sleep Syndrome Treatment Sales Market Share by Application (2024-2034)
5.2 Global Short Sleep Syndrome Treatment Revenue by Application (2024-2034)
5.2.1 Global Short Sleep Syndrome Treatment Revenue by Application (2024-2024)
5.2.2 Global Short Sleep Syndrome Treatment Revenue by Application (2024-2034)
5.2.3 Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2024-2034)
5.3 Global Short Sleep Syndrome Treatment Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck & co.
6.1.1 Merck & co. Corporation Information
6.1.2 Merck & co. Description and Business Overview
6.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck & co. Short Sleep Syndrome Treatment Product Portfolio
6.1.5 Merck & co. Recent Developments/Updates
6.2 Mylan N.V.
6.2.1 Mylan N.V. Corporation Information
6.2.2 Mylan N.V. Description and Business Overview
6.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Mylan N.V. Short Sleep Syndrome Treatment Product Portfolio
6.2.5 Mylan N.V. Recent Developments/Updates
6.3 Paratek pharmaceuticals
6.3.1 Paratek pharmaceuticals Corporation Information
6.3.2 Paratek pharmaceuticals Description and Business Overview
6.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Portfolio
6.3.5 Paratek pharmaceuticals Recent Developments/Updates
6.4 Pfizer Inc.
6.4.1 Pfizer Inc. Corporation Information
6.4.2 Pfizer Inc. Description and Business Overview
6.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Pfizer Inc. Short Sleep Syndrome Treatment Product Portfolio
6.4.5 Pfizer Inc. Recent Developments/Updates
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Corporation Information
6.5.2 Sanofi S.A. Description and Business Overview
6.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sanofi S.A. Short Sleep Syndrome Treatment Product Portfolio
6.5.5 Sanofi S.A. Recent Developments/Updates
6.6 Sumitomo Dainippon pharma Co. Ltd.
6.6.1 Sumitomo Dainippon pharma Co. Ltd. Corporation Information
6.6.2 Sumitomo Dainippon pharma Co. Ltd. Description and Business Overview
6.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Portfolio
6.6.5 Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates
6.7 Takeda Pharmaceuticals Company Ltd.
6.6.1 Takeda Pharmaceuticals Company Ltd. Corporation Information
6.6.2 Takeda Pharmaceuticals Company Ltd. Description and Business Overview
6.6.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Portfolio
6.7.5 Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.8.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Portfolio
6.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.9 Vanda Pharmaceuticals Inc.
6.9.1 Vanda Pharmaceuticals Inc. Corporation Information
6.9.2 Vanda Pharmaceuticals Inc. Description and Business Overview
6.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Portfolio
6.9.5 Vanda Pharmaceuticals Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short Sleep Syndrome Treatment Industry Chain Analysis
7.2 Short Sleep Syndrome Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short Sleep Syndrome Treatment Production Mode & Process
7.4 Short Sleep Syndrome Treatment Sales and Marketing
7.4.1 Short Sleep Syndrome Treatment Sales Channels
7.4.2 Short Sleep Syndrome Treatment Distributors
7.5 Short Sleep Syndrome Treatment Customers
8 Short Sleep Syndrome Treatment Market Dynamics
8.1 Short Sleep Syndrome Treatment Industry Trends
8.2 Short Sleep Syndrome Treatment Market Drivers
8.3 Short Sleep Syndrome Treatment Market Challenges
8.4 Short Sleep Syndrome Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Short Sleep Syndrome Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Short Sleep Syndrome Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Short Sleep Syndrome Treatment Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Short Sleep Syndrome Treatment Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Short Sleep Syndrome Treatment Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Short Sleep Syndrome Treatment Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Short Sleep Syndrome Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Short Sleep Syndrome Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short Sleep Syndrome Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Short Sleep Syndrome Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short Sleep Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Sleep Syndrome Treatment Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Short Sleep Syndrome Treatment Sales by Region (2024-2024) & (K Units)
Table 18. Global Short Sleep Syndrome Treatment Sales Market Share by Region (2024-2024)
Table 19. Global Short Sleep Syndrome Treatment Sales by Region (2024-2034) & (K Units)
Table 20. Global Short Sleep Syndrome Treatment Sales Market Share by Region (2024-2034)
Table 21. Global Short Sleep Syndrome Treatment Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Short Sleep Syndrome Treatment Revenue Market Share by Region (2024-2024)
Table 23. Global Short Sleep Syndrome Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Short Sleep Syndrome Treatment Revenue Market Share by Region (2024-2034)
Table 25. North America Short Sleep Syndrome Treatment Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Short Sleep Syndrome Treatment Sales by Country (2024-2024) & (K Units)
Table 27. North America Short Sleep Syndrome Treatment Sales by Country (2024-2034) & (K Units)
Table 28. North America Short Sleep Syndrome Treatment Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Short Sleep Syndrome Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Short Sleep Syndrome Treatment Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Short Sleep Syndrome Treatment Sales by Country (2024-2024) & (K Units)
Table 32. Europe Short Sleep Syndrome Treatment Sales by Country (2024-2034) & (K Units)
Table 33. Europe Short Sleep Syndrome Treatment Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Short Sleep Syndrome Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Short Sleep Syndrome Treatment Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Short Sleep Syndrome Treatment Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Short Sleep Syndrome Treatment Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Short Sleep Syndrome Treatment Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Short Sleep Syndrome Treatment Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Short Sleep Syndrome Treatment Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Short Sleep Syndrome Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Short Sleep Syndrome Treatment Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Short Sleep Syndrome Treatment Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Short Sleep Syndrome Treatment Sales (K Units) by Type (2024-2024)
Table 51. Global Short Sleep Syndrome Treatment Sales (K Units) by Type (2024-2034)
Table 52. Global Short Sleep Syndrome Treatment Sales Market Share by Type (2024-2024)
Table 53. Global Short Sleep Syndrome Treatment Sales Market Share by Type (2024-2034)
Table 54. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2024-2024)
Table 57. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2024-2034)
Table 58. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2024-2024)
Table 59. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2024-2034)
Table 60. Global Short Sleep Syndrome Treatment Sales (K Units) by Application (2024-2024)
Table 61. Global Short Sleep Syndrome Treatment Sales (K Units) by Application (2024-2034)
Table 62. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2024-2024)
Table 63. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2024-2034)
Table 64. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2024-2024)
Table 67. Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2024-2034)
Table 68. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2024-2024)
Table 69. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2024-2034)
Table 70. Merck & co. Corporation Information
Table 71. Merck & co. Description and Business Overview
Table 72. Merck & co. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck & co. Short Sleep Syndrome Treatment Product
Table 74. Merck & co. Recent Developments/Updates
Table 75. Mylan N.V. Corporation Information
Table 76. Mylan N.V. Description and Business Overview
Table 77. Mylan N.V. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Mylan N.V. Short Sleep Syndrome Treatment Product
Table 79. Mylan N.V. Recent Developments/Updates
Table 80. Paratek pharmaceuticals Corporation Information
Table 81. Paratek pharmaceuticals Description and Business Overview
Table 82. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product
Table 84. Paratek pharmaceuticals Recent Developments/Updates
Table 85. Pfizer Inc. Corporation Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Pfizer Inc. Short Sleep Syndrome Treatment Product
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Sanofi S.A. Corporation Information
Table 91. Sanofi S.A. Description and Business Overview
Table 92. Sanofi S.A. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Sanofi S.A. Short Sleep Syndrome Treatment Product
Table 94. Sanofi S.A. Recent Developments/Updates
Table 95. Sumitomo Dainippon pharma Co. Ltd. Corporation Information
Table 96. Sumitomo Dainippon pharma Co. Ltd. Description and Business Overview
Table 97. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product
Table 99. Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates
Table 100. Takeda Pharmaceuticals Company Ltd. Corporation Information
Table 101. Takeda Pharmaceuticals Company Ltd. Description and Business Overview
Table 102. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product
Table 104. Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates
Table 105. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 106. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product
Table 109. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 110. Vanda Pharmaceuticals Inc. Corporation Information
Table 111. Vanda Pharmaceuticals Inc. Description and Business Overview
Table 112. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product
Table 114. Vanda Pharmaceuticals Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Short Sleep Syndrome Treatment Distributors List
Table 118. Short Sleep Syndrome Treatment Customers List
Table 119. Short Sleep Syndrome Treatment Market Trends
Table 120. Short Sleep Syndrome Treatment Market Drivers
Table 121. Short Sleep Syndrome Treatment Market Challenges
Table 122. Short Sleep Syndrome Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Short Sleep Syndrome Treatment
Figure 2. Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Short Sleep Syndrome Treatment Market Share by Type in 2022 & 2034
Figure 4. Benzodiazepines Product Picture
Figure 5. Nonbenzodiazepines Product Picture
Figure 6. Antidepressants Product Picture
Figure 7. Orexin Antagonist Product Picture
Figure 8. Melatonin Antagonist Product Picture
Figure 9. Other Product Picture
Figure 10. Global Short Sleep Syndrome Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Short Sleep Syndrome Treatment Market Share by Application in 2022 & 2034
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Short Sleep Syndrome Treatment Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Short Sleep Syndrome Treatment Market Size (2024-2034) & (US$ Million)
Figure 17. Global Short Sleep Syndrome Treatment Sales (2024-2034) & (K Units)
Figure 18. Global Short Sleep Syndrome Treatment Average Price (US$/Unit) & (2024-2034)
Figure 19. Short Sleep Syndrome Treatment Report Years Considered
Figure 20. Short Sleep Syndrome Treatment Sales Share by Manufacturers in 2022
Figure 21. Global Short Sleep Syndrome Treatment Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Short Sleep Syndrome Treatment Players: Market Share by Revenue in 2022
Figure 23. Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 24. Global Short Sleep Syndrome Treatment Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 25. North America Short Sleep Syndrome Treatment Sales Market Share by Country (2024-2034)
Figure 26. North America Short Sleep Syndrome Treatment Revenue Market Share by Country (2024-2034)
Figure 27. United States Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Canada Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Europe Short Sleep Syndrome Treatment Sales Market Share by Country (2024-2034)
Figure 30. Europe Short Sleep Syndrome Treatment Revenue Market Share by Country (2024-2034)
Figure 31. Germany Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. France Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. U.K. Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Italy Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Russia Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Asia Pacific Short Sleep Syndrome Treatment Sales Market Share by Region (2024-2034)
Figure 37. Asia Pacific Short Sleep Syndrome Treatment Revenue Market Share by Region (2024-2034)
Figure 38. China Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Japan Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. South Korea Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. India Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Australia Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. China Taiwan Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America Short Sleep Syndrome Treatment Sales Market Share by Country (2024-2034)
Figure 46. Latin America Short Sleep Syndrome Treatment Revenue Market Share by Country (2024-2034)
Figure 47. Mexico Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Short Sleep Syndrome Treatment Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Short Sleep Syndrome Treatment Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. UAE Short Sleep Syndrome Treatment Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Short Sleep Syndrome Treatment by Type (2024-2034)
Figure 56. Global Revenue Market Share of Short Sleep Syndrome Treatment by Type (2024-2034)
Figure 57. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2024-2034)
Figure 58. Global Sales Market Share of Short Sleep Syndrome Treatment by Application (2024-2034)
Figure 59. Global Revenue Market Share of Short Sleep Syndrome Treatment by Application (2024-2034)
Figure 60. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2024-2034)
Figure 61. Short Sleep Syndrome Treatment Value Chain
Figure 62. Short Sleep Syndrome Treatment Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed